Company intelligence / Profile preview

Additive Surgical

Adelaide (Kent Town), South Australia, Australia

Ownership: Private
Development stage: Other

Overview

Additive Surgical has commercialized a portfolio of proprietary, off-the-shelf 3D-printed titanium spinal implant devices featuring PorOssity biomimetic lattices designed to promote bone growth and improve clinical outcomes. Products are CE marked, TGA registered, Prosthesis listed and actively distributed in Australia and, through partnership, being launched in the UK in 2025.

Therapeutic areas: OtherNeurology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Osteotec (exclusive UK distribution)Tsunami Medical (joint manufacturing and technology for Australian/NZ market)Flinders University (R&D collaboration for biomimetic lattice implants)

Beyond the preview

Go deeper on Additive Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Additive Surgical.

Explore the full profile